UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Learn the key wash sale rules disallowing crypto losses in 2026 and how to approach reporting and avoidance strategies.
22,404 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Investors are weighing UnitedHealth Group as a 2026 contender. This guide breaks down the key drivers, risks, and a c...
Two very different retail giants compete for investors' attention in 2026. This guide breaks down whether Abercrombie...
A March 2026 market backdrop pushes index fund investing to the forefront as brokers compete on fees, access to major...
A fresh look at Fossil's Q1 2026 earnings expectations. Learn what to watch in the report, how margins may trend, and...
As 2026 unfolds, I’m leaning into one magnificent ETF that fits my high-conviction approach. Here’s why this fund sta...
Applied Materials reports a robust free cash flow figure for Q1 2026, but the stock fell as traders questioned how lo...
Brokerage mergers are reshaping the mortgage landscape as Compass International Holdings, Real, and eXp expand their ...
Could Costco surprise investors with another special dividend in 2026? This guide dives into history, cash flow, and ...
March 2026 brings a wave of Koyfin alternatives as traders seek deeper data, faster alerts, and cleaner interfaces. H...
Barclays boosts its view on Charles Schwab after the firm guides for higher 2026 revenue and reports stronger Q1 resu...
As the first half 2026 over wraps up, AI stocks show a rotating leadership. This article highlights two compelling be...